Synaptosomal response to oxidative stress: Effect of vinpocetine

Free Radical Research

Volumn 32, Issue 1, 2000, Pages 57-66

  Santos, Maria S ^a   Duarte, Ana I ^a   Moreira, Paula I ^a   Oliveira, Catarina R ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Neuroprotection; Oxidative stress; Synaptosomes; Vinpocetine

Indexed keywords

ANTIOXIDANT; FERROUS ASCORBATE; FLUORESCEIN DERIVATIVE; OXYGEN; REACTIVE OXYGEN METABOLITE; RHODAMINE 123; THIOBARBITURIC ACID REACTIVE SUBSTANCE; VINPOCETINE;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BIOACCUMULATION; BRAIN OXYGEN CONSUMPTION; BRAIN PROTECTION; BRAIN SYNAPTOSOME; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 0033988559     PISSN: 10715762     EISSN: None     Source Type: Journal    
DOI: 10.1080/10715760000300061     Document Type: Article

References (56)

1. B.K. Siesjo, C.D. Agarth and F. Begtsson (1989). Free radicals and brain damage. Cerebrovascular Brain Metabolism Reviews, 1, 165-211.
2. B. Halliwell (1992). Reactive oxygen species and the central nervous system. Journal of Neurochemistry, 59, 1609-1623.
3. J.T. Coyle and P. Puttfarcken (1993). Oxidative stress, glutamate and neurodegenerative disorders. Science, 262, 689-695.
4. C.W. Olanow (1993). A radical hypotheses for neurodegeneration. Trends in Neurosciences, 16, 439-444.
5. B. Halliwell and J.M.C. Gutteridge (1994). Oxygen toxicity, oxygen radicals, transition metals and disease. Biochemical Journal, 219, 1-14.
6. J.W. Phillis (1994). A "radical" view of cerebral ischemic injury. Progress in Neurobiology, 42, 441-498.
7. B. Halliwell and J.M.C. Gutteridge (1985). Oxygen radicals and the nervous system. Trends in Neurosciences, 8, 22-26.
8. P.H. Evans (1993). Free radicals in brain metabolism and pathology. British Medical Bulletin, 49, 577-587.
9. J.B. Schultz, D.R. Henshaw, D. Siwek, B.G. Jenkins, R.J. Ferrante, P.B. Cipolloni, N.W. Kowall, B.R. Rosen and M.F. Beal (1995). Involvement of free radicals in excitotoxicity in vivo. Journal of Neurochemistry, 64, 2239-2247.
10. N.R. Sims and E. Zaidan (1995). Biochemical changes associated with selective neuronal death following short-term cerebral ischaemia. International Journal of Biochemistry and Cell Biology, 27, 531-550.
11. E.D. Hall and J.M. Braughler (1989). Central nervous system trauma and stroke II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radicals in Biology and Medicine, 6, 303-313.
12. D. Pellegrini-Giampietro, G. Cherici, M. Alesiani, V. Carla and F. Moroni (1990). Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. Journal of Neuroscience, 10, 1035-1041.
13. O. Globus, W.D. Alonso, W.D. Dietrich, R. Busto and M.D. Ginsberg (1995). Glutamate release and free radical production following brain injury: effects of post traumatic hypothermia. Journal of Neurochemistry, 65, 1704-1711.
14. E. Lancelot, J. Callebert, M.L. Revaud, R.G. Boulu and M. Plotkine (1995). Detection of hydroxyl radicals in rat striatum during transient focal cerebral ischemia: possible implication in tissue damage. Neuroscience Letters, 197, 85-88.
15. T.K. McIntosh (1993). Novel pharmacological therapies in the treatment of experimental traumatic brain injury: a review. Journal of Neurotrauma, 10, 215-261.
16. N. Nakao, E.M. Grasbon-Frodl, H. Widner and P. Brundin (1996). Antioxidant treatment protects neurons against striatal neurons excitotoxic insults. Neuroscience, 73, 185-200.
17. K. Hensley, J.M. Carney, C.A. Stewart, T. Tabatabaie, Q. Pye and R.A. Floyd (1997). Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies In Neuroprotective Agents and Cerebral Ischemia (A.R. Green and A.J. Cross, Eds.), pp. 299-317, Academic Press, New York.
18. G.A. King (1987). Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice. Archives internationals de Pharmacodynamie et de Thérapie, 286, 299-307.
19. D. Sauer, R. Rischke, T. Beck, C. Roßberg, H.D. Mennel, G.W. Bielenberg and J. Krieglstein (1988). Vinpocetine prevents ischemic cell damage in rat hippocampus. Life Sciences, 43, 1733-1739.
20. M. Miyamoto, T.M. Murphy, R.L. Schnaar and J.T. Coyle (1989). Antioxidants protect glutamate-induced cytotoxicity in a neuronal cell line. Journal of Pharmacology and Experimental Therapeutics, 250, 1132-1140.
21. S.L. Erdö, C. Ning-sheng, J.R. Wolff and Béla Kiss (1990). Vinpocetine protects against excitotoxic cell death in primary cultures of rat cerebral cortex. European Journal of Pharmacology, 187, 551-553.
22. V. Lakics, M.G. Sebestyén and S.L. Erdö (1995). Vinpocetine is a highly potent neuroprotectant against veratridine-induced cell death in primary cultures of rat cerebral cortex. Neuroscience Letters, 185, 127-130.
23. i rise in synaptosomes. NeuroReport, 9, 1849-1853.
24. J. Schmidt (1990). Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats. Biomedica Biochimica Acta, 49, 413-419.
25. 2+ uptake in synaptosomes. Brain Research, 609, 117-123.
26. S.M. Cardoso, C. Pereira and C.R. Oliveira (1998). The protective effect of Vitamin E, Idebenone and reduced glutathione on free radical mediated injury in rat brain synaptosomes. Biochemical and Biophysical Research Communications, 246, 703-710.
27. F. Hajós (1975). An improved method for the preparation of synaptosomal fractions in high purity. Brain Research, 93, 485-489.
28. L. Ernster and K. Nordenbrand (1967). Microsomal lipid peroxidation. Methods in Enzymology, 10, 574-580.
29. T.C. Dinis, V.M.C. Madeira and L. Almeida (1994). Action of phenolic derivatives (Acetaminophen, salicylate, and 5-aminosalicylate) as inhibitors of membrane lipid peroxidation and as peroxyl radical scavengers. Archives of Biochemistry and Biophysics, 315, 161-169.
30. D.A. Bass, J.W. Parce, L.R. Dechatelet, P. Szejda, M.C. Seeds and M. Thomas (1983). Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. Journal of Immunology, 130, 1910-1917.
31. 2 in cultured endothelial cells. Archives of Biochemistry and Biophysics, 302, 348-355.
32. P. Carter (1971). Spectrophotometric determination of serum iron at tbe submicrogram level with a new reagent (ferrozine). Analytical Biochemistry, 40 450-458.
33. J.D. Rubinstein, E.J. Lesnefsky, R.M. Byler, P.V. Fennessey and L.D. Horwitz (1992) Trolox C, a lipid-soluble membrane protective agent, attenuates myocardial injury from ischemia and reperfusion. Free Radicals in Biology and Medicine, 13, 627-634.
34. J.M.C. Gutteridge and B. Halliwell (1990). The measurements and mechanism of lipid peroxidation in biological systems. Trends in Biochemical Sciences, 15, 129-135.
35. H. Sassa, Y. Takaishi and H. Terada (1990). The triterpeno celastrol as a very potent inhibitor of lipid peroxidation in mitochondria. Biochemical and Biophysical Research Communications, 172, 890-897.
36. D.R. Janero (1990). Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radicals in Biology and Medicine, 9, 515-540.
37. J.K. Callaway, P.M. Beart and B. Jarrott (1998). A reliable procedure for comparison of antioxidants in rat brain homogenates. Journal of Pharmacology and Toxicological Methods, 39, 155-162.
38. C.P. LeBel, S.F. Ali, M. McKee and S.C. Bondy (1990). Organometal-induced increases in oxygen reactive species: the potential of 2′-7′-dichlorofluorescein diacetate as an index of neurotoxic damage. Toxicology and Applied Pharmacology, 104, 17-24.
39. N.W. Kooy, J.A. Royall and H. Ischiropoulos (1997). Oxidation of 2′,7′-Dichlorofluorescein by peroxynitrite. Free Radical Research, 27, 245-257.
40. H. Possel, H. Noack, W. Augustin, G. Keilhoff and G. Wolf (1987). 2,7-Dihydrodichlorofluorescein diacetate as a fluorescent marker for peroxynitrite formation. FEBS Letters, 416, 175-178.
41. L.M. Henderson and J.B. Chappell (1993). Dihydrorhodamine 123: a fluorescent probe for superoxide generation. European Journal of Biochemistry, 217, 973-980.
42. N.W. Kooy, J.A. Royall, H. Ischiropoulos and J.S. Beckman (1994). Peroxynitrite-mediated oxidation of dihydrorhodamine 123. Free Radicals in Biology and Medicine, 16, 149-156.
43. L.A. Witting (1980). Vitamin E and lipid antioxidants in free-radical initiated reaction. In Free Radical in Biology (W.A. Pryor, Ed.), pp. 295-319, Academic Press, New York.
44. P. Agostinho, C.B. Duarte and C.R. Oliveira (1997). Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: effect of antioxidants. FASEB Journal, 11, 154-163.
45. A.C. Rego, M.S. Santos, M.T. Proença and C.R. Oliveira (1998). Influence of vitamin E on retinal cell survival. Toxicology, 128, 113-124.
46. S.M. Cardoso, C. Pereira and C.R. Oliveira (1999). Mitochondrial function is differentially affected upon oxidative stress. Free Radicals in Biology and Medicine, 26, 3-13.
47. + concentration increases in cultured retinal cells under oxidative stress conditions. Neuroscience Research, 25, 343-351.
48. C. Romano, M.T. Price and J.W. Olney (1995). Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina. Journal of Neurochemistry, 65, 59-67.
49. + channels in rat cortical neurons. European Journal of Pharmacology, 273, 303-306.
50. 3H] MK-801. European Journal of Pharmacology, 209, 119-128.
51. B. Kiss, N.S. Cai and S.L. Erde (1991). Vinpocetine preferentially antagonizes quisqualate/AMPA receptor responses: evidence from release and ligand binding studies. European Journal of Pharmacology, 209, 109-112.
52. M. Suno and A. Nagaoka (1984). Inhibition of lipid peroxidation by a novel compound (CV-2619) in brain mitochondria and mode of action of inhibition. Biochemical and Biophysical Research Communications, 125, 1046-1052.
53. J. Krieglstein and R. Rischke (1991). Vinpocetine increases the neuroprotective effect of adenosine. European Journal of Pharmacology, 205, 7-10.
54. K.A. Rudolphi, P. Schubert, F.E. Parkinson and B.B. Fredholm (1992). Neuroprotective role of adenosine in ischemia. Trends in Pharmacological Sciences, 13, 439-445.
55. P. Pudleiner and L. Vereczkey (1993). Study on the absorption of vinpocetine and apovincaminic acid. European Journal of Drug Metabolism and Pharmacokinetics, 18, 317-325.
56. L. Vereczkey, G. Czira, J. Tamás, Z.S. Szentirmai, Z. Botár and L. Szporny (1979). Pharmacokinetics of vinpocetine in humans. Arzneimittel Forschung, 29, 957-960.